The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Advan Cell Appoints Justyna Kelly As Chief Technology Officer and François Gaudet As Chief Scientific Officer
PRIVATEJun 08, 2026•9 days ago
Position
Chief Scientific Officer
Company
AdvanCell
François Gaudet
SydneyBiotechnologyHealth CareTherapeutics
Description
AdvanCell has announced the appointments of Justyna Kelly as Chief Technology Officer and François Gaudet as Chief Scientific Officer to enhance its executive leadership team. This move is part of the company’s strategy to accelerate its U.S. expansion and strengthen its targeted alpha therapy platform.
Company Information
Company
AdvanCell
Location
Macquarie Street
Sydney, New South Wales, Australia
About
AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By leveraging its proprietary Lead-212 platform, advanced and scalable manufacturing capabilities and world-class clinical development capabilities, AdvanCell aims to deliver novel treatments that improve outcomes for patients with cancer globally.